AI assistant
Sending…
PHARMX TECHNOLOGIES LIMITED — Regulatory Filings 2019
Feb 24, 2019
65560_rns_2019-02-24_16a39767-dfde-43c0-ac95-4d55a2021ec3.pdf
Regulatory Filings
Open in viewerOpens in your device viewer

Market Release
25 February 2019
Results of Extraordinary General Meeting held on Monday, 25 February 2019
In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, Corum Group Limited advises the results of voting and the proxies received in respect of each resolution at the Extraordinary General Meeting held today per the attached schedule.
David Clarke Company Secretary The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth).
* Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.
| Resolution details | Instructions given to validly appointed proxies (as at proxy close) |
Number of votes cast on the poll (where applicable) |
Resolution Result |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Resolution | Resolution Type |
For | Against | Proxy's Discretion |
Abstain | For | Against | Abstain* | Carried / Not Carried |
| 1 Re-election of Bill Paterson as a Director | Ordinary | 159,280,618 83.30% |
31,820,100 16.64% |
107,885 0.06% |
608,000 | Carried on a show of hands | Carried | ||
| 2 Re-election of Gregor Aschoff as a Director | Ordinary | 158,991,677 83.15% |
32,109,041 16.79% |
107,885 0.06% |
608,000 | Carried on a show of hands | Carried | ||
| 3 Re-election of Matthew Bottrell as a Director | Ordinary | 158,992,320 83.15% |
32,101,398 16.79% |
114,885 0.06% |
608,000 | Carried on a show of hands | Carried | ||
| 4 Issue of Shares to a Non-Executive Director - Bill Paterson |
Ordinary | 18,313,280 36.36% |
31,944,978 63.43% |
104,385 0.21% |
12,700 | 18,447,665 33.59% |
36,466,192 66.41% |
6,809,063 | Not Carried |
| 5 Issue of Shares to an Executive Director - Gregor Aschoff |
Ordinary | 18,308,280 36.35% |
31,949,978 63.44% |
104,385 0.21% |
12,700 | 18,442,665 33.58% |
36,471,192 66.42% |
6,809,063 | Not Carried |
| 6 Issue of Shares to a Non-Executive Director - Matthew Bottrell |
Ordinary | 17,959,423 35.66% |
32,298,835 64.13% |
104,385 0.21% |
12,700 | 18,093,808 32.95% |
36,820,049 67.05% |
6,809,063 | Not Carried |
Corum Group Limited 2019 Extraordinary General Meeting Monday, 25 February 2019 Voting Results
More from PHARMX TECHNOLOGIES LIMITED
Regulatory Filings
2026
May 4
Director's Dealing
2026
Mar 12
Board/Management Information
2026
Mar 12
Major Shareholding Notification
2026
Mar 11
Share Issue/Capital Change
2026
Feb 25
Share Issue/Capital Change
2026
Feb 25
Interim / Quarterly Report
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Investor Presentation
2026
Feb 24
Share Issue/Capital Change
2026
Feb 22